Zacks: Brokerages Anticipate Surgery Partners Inc (NASDAQ:SGRY) Will Announce Quarterly Sales of $449.18 Million

Share on StockTwits

Brokerages expect Surgery Partners Inc (NASDAQ:SGRY) to post $449.18 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Surgery Partners’ earnings, with the highest sales estimate coming in at $451.52 million and the lowest estimate coming in at $448.00 million. Surgery Partners posted sales of $444.78 million during the same quarter last year, which suggests a positive year-over-year growth rate of 1%. The company is scheduled to report its next earnings report on Thursday, August 8th.

On average, analysts expect that Surgery Partners will report full-year sales of $1.85 billion for the current year, with estimates ranging from $1.82 billion to $1.88 billion. For the next year, analysts expect that the business will report sales of $2.01 billion, with estimates ranging from $1.91 billion to $2.12 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for Surgery Partners.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.39) by ($0.03). The firm had revenue of $416.80 million during the quarter, compared to analyst estimates of $421.41 million. Surgery Partners had a negative return on equity of 4.01% and a negative net margin of 11.59%. The business’s revenue was up 1.3% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.26) earnings per share.

A number of analysts have recently issued reports on SGRY shares. Stifel Nicolaus set a $12.00 price target on Surgery Partners and gave the stock a “hold” rating in a research note on Wednesday, May 8th. BidaskClub raised Surgery Partners from a “hold” rating to a “buy” rating in a research note on Saturday, March 16th. Finally, Zacks Investment Research raised Surgery Partners from a “strong sell” rating to a “hold” rating in a research note on Wednesday, April 24th. Two analysts have rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the stock. Surgery Partners has an average rating of “Hold” and an average target price of $17.60.

In other Surgery Partners news, Director Adam T. Feinstein sold 7,865 shares of the business’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $9.95, for a total transaction of $78,256.75. Following the transaction, the director now owns 8,895 shares of the company’s stock, valued at $88,505.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.30% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Principal Financial Group Inc. boosted its stake in Surgery Partners by 9.5% during the fourth quarter. Principal Financial Group Inc. now owns 19,325 shares of the company’s stock worth $189,000 after buying an additional 1,672 shares during the last quarter. BNP Paribas Arbitrage SA boosted its stake in Surgery Partners by 3.0% during the first quarter. BNP Paribas Arbitrage SA now owns 104,284 shares of the company’s stock worth $1,176,000 after buying an additional 3,068 shares during the last quarter. California Public Employees Retirement System boosted its stake in Surgery Partners by 11.3% during the fourth quarter. California Public Employees Retirement System now owns 36,917 shares of the company’s stock worth $361,000 after buying an additional 3,739 shares during the last quarter. Quantamental Technologies LLC acquired a new position in Surgery Partners during the first quarter worth $50,000. Finally, Metropolitan Life Insurance Co. NY raised its position in Surgery Partners by 351.4% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 6,766 shares of the company’s stock valued at $66,000 after purchasing an additional 5,267 shares during the period. 96.75% of the stock is currently owned by institutional investors.

Shares of NASDAQ:SGRY traded down $0.16 during trading on Tuesday, reaching $7.90. The stock had a trading volume of 259,128 shares, compared to its average volume of 359,082. The company has a current ratio of 1.49, a quick ratio of 1.37 and a debt-to-equity ratio of 2.20. The stock has a fifty day moving average of $8.81. The company has a market cap of $390.48 million, a PE ratio of -3.22 and a beta of 2.28. Surgery Partners has a 1-year low of $7.64 and a 1-year high of $18.70.

About Surgery Partners

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

See Also: Cost of Goods Sold (COGS)

Get a free copy of the Zacks research report on Surgery Partners (SGRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Brokerages Anticipate Surgery Partners Inc  to Post -$0.14 Earnings Per Share
Brokerages Anticipate Surgery Partners Inc to Post -$0.14 Earnings Per Share
Brokerages Set HB Fuller Co  PT at $55.60
Brokerages Set HB Fuller Co PT at $55.60
Zacks: Brokerages Anticipate Surgery Partners Inc  Will Announce Quarterly Sales of $449.18 Million
Zacks: Brokerages Anticipate Surgery Partners Inc Will Announce Quarterly Sales of $449.18 Million
South State Corp  Receives Consensus Rating of “Hold” from Brokerages
South State Corp Receives Consensus Rating of “Hold” from Brokerages
Analysts Set Potbelly Corp  PT at $8.50
Analysts Set Potbelly Corp PT at $8.50
California Resources Corp  Expected to Post Earnings of $0.53 Per Share
California Resources Corp Expected to Post Earnings of $0.53 Per Share


© 2006-2019 Ticker Report